Abstract
Objectives
To develop a recombinant strain of Bacillus thuringiensis that synthesizes two bacteriocins that enhance the antibacterial potency of the strain and that could have applied clinical and industrial value.
Results
We cloned the thurincin H cluster into the pHT3101 vector by assembling two genetic cassettes harboring genes for the synthesis, modification, immunity and transport of thurincin H. This construct was used to transform a thurincin H-sensitive strain of B. thuringiensis that synthesizes the kenyacin 404 to generate the recombinant Btk 404/pThurH which was immune to thurincin H and produces bacteriocins of approximately 3 kDa. A significant increase in the inhibitory activity, respectively, ~ 40 and 300%, was observed when compared with parental Btm 269 and Btk 404. Btk 404/pThurH showed increased activity against ten Gram-positive bacteria, including B. cereus, Listeria monocytogenes and B. pseudomycoides, and the Gram-negative bacterium, Sphingobacterium cabi. However, an antagonistic effect against Vibrio parahaemolyticus, relative to native strains, was observed.
Conclusions
We have generated a recombinant strain of B. thuringiensis that co-synthesizes two bacteriocins (kenyacin 404, thurincin H) with improved inhibitory activity, when compared with parental strains. To our knowledge, this is the first study that shows that B. thuringiensis could be manipulated to produce two bacteriocins, one being of heterologous origin, that enhance the antibacterial activity of the recombinant strain.
Similar content being viewed by others
References
Alvarez-Siero P, Montalbán-López M, Mu D, Kuipers OP (2016) Bacteriocins of lactic acid bacteria: extending the family. Appl Microbiol Biotechnol 100:2939–2951
Back A, Borges F, Mangavel C, Paris C, Rondags E, Kapel R, Aymes A, Rogniaux H, Pavlovic M, van Heel AJ, Kuipers OP, Revol-Junelles A-M, Cailliez-Grimal C (2016) Recombinant pediocin in Lactococcus lactis: increased production by propeptide fusion and improved potency by co-production with PedC. Microb Biotechnol 9:466–477
Barboza-Corona JE, Vázquez-Acosta H, Bideshi DK, Salcedo-Hernández R (2007) Bacteriocin-like inhibitor substances produced by Mexican strains of Bacillus thuringiensis. Arch Microbiol 187:117
Barboza-Corona JE, Delgadillo- Ángeles JL, Castañeda-Ramírez JC, Barboza-Pérez UE, Casados-Vázquez LE, Bideshi DK, del Rincón-Castro MC (2014) Bacillus thuringiensis subsp. kurstaki HD1 as a factory to synthesize alkali-labile ChiA74∆sp chitinase inclusions, Cry crystals and spores for applied use. Microb Cell Fact 13:15
Bideshi DK, Park H-W, Hice RH, Wirth MC, Federici BA (2017) Highly effective broad spectrum chimeric larvicide that targets vector mosquitoes using a lipophilic protein. Sci Rep 7:11282
Casados-Vázquez L, Bideshi D, Barboza-Corona J (2017) The thnR gene is a negative transcription regulator of the thurincin H genetic cassette in Bacillus thuringiensis subsp. morrisoni. Arch Microbiol 199:385–390
Casados-Vázquez L, Bideshi D, Barboza-Corona J (2018) Regulator ThnR and the ThnDE ABC transporter proteins confer autoimmunity to thurincin H in Bacillus thuringiensis. Antonie Van Leeuwenhoek. https://doi.org/10.1007/s10482-018-1124-7
Chen H, Zhong Q (2017) Lactobionic acid enhances the synergistic effect of nisin and thymol against Listeria monocytogenes Scott A in tryptic soy broth and milk. Int J Food Microbiol 260:36–41
Chi H, Holo H (2018) Synergistic antimicrobial activity between the broad spectrum bacteriocin garvicin KS and nisin, farnesol and polymyxin B against Gram-positive and Gram-negative bacteria. Curr Microbiol 75:272–277
De la Fuente-Salcido N, Casados-Vázquez L, Barboza-Corona JE (2013) Bacteriocins of Bacillus thuringiensis can expand the potential of this bacterium to other areas rather than limit its use only as microbial insecticide. Can J Microbiol 59:515–522
Fisher RA, Gollan B, Helaine S (2017) Persistent bacterial infection and persister cells. Nat Rev Microbiol 15:453–464
Gutiérrez-Chávez AJ, Martínez-Ortega EA, Valencia-Posadas M, León Galván MF, Fuente-Salcido NM, Bideshi DK, Barboza-Corona JE (2016) Potential use of Bacillus thuringiensis bacteriocins to control antibiotic-resistant bacteria associated with mastitis in dairy goats. Folia Microbiol 61:11–19
Juárez-Hernández EO, Casados-Vázquez LE, Del Rincón-Castro MC, Salcedo-Hernández R, Bideshi DK, Barboza-Corona JE (2015) Bacillus thuringiensis subsp. israelensis producing endochitinase ChiA74Δsp inclusion and its improved activity against Aedes aegypti. J Appl Microbiol 119:1692–1699
Kitazaki K, Koga S, Nagatoshi K, Kuwano K, Zendo T, Nakayama J, Sonomoto K, Ano H, Katamoto H (2017) In vitro synergistic activities of cefazolin and nisin A against mastitis pathogens. J Vet Med Sci 79:1472–1479
Lee H, Churey J, Worobo R (2009) Biosynthesis and transcriptional analysis of thurincin H, a tandem repeated bacteriocin genetic locus, produced by Bacillus thuringiensis SF361. FEMS Microbiol Lett 299:205–213
Mathur H, Field D, Rea MC, Cotter PD, Hill C, Ross RP (2017) Bacteriocin-antimicrobial synergy: a medical and food perspective. Front Microbiol 8:1205
Ni Z-J, Zhang X-Y, Liu F, Wang M, Hao R-H, Ling P-X, Zhu X-Q (2017) Effect of co-overexpression of nisin key genes on nisin production improvement in Lactococcus lactis LS01. Probiotics Antimicrob Prot 9:204–212
Olempska-Beer ZS, Merker RI, Ditto MD, DiNovi MJ (2006) Food processing enzymes from recombinant organism: a review. Regul Toxicol Pharmacol 45:144–158
Park H-W, Hice RH, Federici BA (2016) Effect of promoters and plasmid copy number on CtyA synthesis and crystal assembly in Bacillus thuringiensis. Curr Microbiol 7:33–40
Rea MC, Sit CS, Clayton E, O’Connor PM, Whittal RM, Zheng J, Veredas JC, Ross P, Hill C (2010) Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci USA 107:9352–9357
Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
Schägger H (2006) Tricine-sds-page. Nat Protoc 1:16–22
Sit C, Van-Belkum M, McKay R, Worobo R, Vederas J (2011) The 3D solution structure of Thurincin H, a bacteriocin with four sulfur to a-carbon crosslinks. Angew Chem Int 50:8718–8721
Wang G, Manns DC, Churey JJ, Worobo RW (2014a) Naturally sensitive Bacillus thuringiensis EG10368 produces thurincin H and acquires immunity after heterologous expression of the one-step-amplified thurincin H gene cluster. J Dairy Sci 97:4115–4119
Wang G, Manns DC, Churey JJ, Worobo RW (2014b) Development of a homologous expression system for and systematic site-directed mutagenesis analysis of thurincin H, a bacteriocin produced by Bacillus thuringiensis SF361. Appl Environ Microbiol 80:3576–3584
Wang G, Feng G, Snyder AB, Manns DC, Churey JJ, Worobo RW (2014c) Bactericidal thurincin H causes unique morphological changes in Bacillus cereus F4552 without affecting membrane permeability. FEMS Microbiol Lett 357:69–76
Wieckowski BM, Hegemann JD, Mielcarek A, Boss L, Burghaus O, Marahiel MA (2015) The PqqD homologous domain of the radical SAM enzyme ThnB is required for thioether bond formation during thurincin H maturation. FEBS Lett 589:1802–1806
Xin B, Zheng J, Liu H, Junhua L, Ruan L, Peng D, Sajid M, Sun M (2016) Thusin, a novel two-component lantibiotic with potent antimicrobial activity against several Gram-positive pathogens. Front Microbiol 7:1–12
Zhang B, Li A, Zuo F, Yu R, Zeng Z, Ma H, Chen S (2016) Recombinant Lactococcus lactis NZ9000 secretes a bioactive kisspeptin that inhibits proliferation and migration of human carcinoma HT-29 cells. Microb Cell Fact 15:102
Acknowledgements
Zuleyka S. Oros-Flores is a graduate student of the Master in BioScience that received a scholarship by “Consejo Nacional de Ciencia y Tecnología” (CONACYT) México. Luz E. Casados-Váquez is a Young Associate Research supported by CONACYT (Grant 269). This study was partially supported by Grant SEP-CONACyT (258220) to J.E. B-C, and “Problemas Nacionales”-CONACYT (Grant 3664) to L.E. C-V.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Oros-Flores, Z.S., Casados-Vázquez, L.E., Bideshi, D.K. et al. Co-synthesis of kenyacin 404 and heterologous thurincin H enhances the antibacterial activity of Bacillus thuringiensis. Biotechnol Lett 40, 1531–1540 (2018). https://doi.org/10.1007/s10529-018-2601-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-018-2601-9